Minqi Zhu
Overview
Explore the profile of Minqi Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao K, Zhu M, Guo L, Gao Z, Cheng J, Sun B, et al.
Front Immunol
. 2025 Feb;
16:1514238.
PMID: 39963131
Objective: To build a new prognostic risk assessment model based on immune cell co-expression networks for predicting overall survival and evaluating the efficacy of immunotherapy for colon cancer patients. Methods:...
2.
Zhang Y, Li B, Gu W, Fan L, Wang X, Xu M, et al.
Discov Oncol
. 2025 Jan;
16(1):36.
PMID: 39804511
Background: A recent study revealed the oncogenic role of box C/D small nucleolar RNA 52 (SNORD52) in hepatocellular carcinoma (HCC) by facilitating the aggressive phenotypes of hepatoma cells. However, the...
3.
Zhu M, Liao G, Wang Y, Mo J, Yi D, Zhang Y, et al.
Front Genet
. 2022 Sep;
13:952528.
PMID: 36118851
According to the TIMER database, large tumor suppressor 2 (LATS2) is differentially expressed in various tumors. However, the correlation between LATS2 and esophageal squamous cell carcinoma (ESCC) and the association...
4.
Zhu M, Gao S, Gao S, Wang Y, Li N, Shen X
Bioengineered
. 2022 Jun;
13(6):14175-14187.
PMID: 35730427
Diabetic retinopathy (DR) represents an important microvascular complication of diabetes, which is the top etiology of vision impairment worldwide. Although interleukin (IL)-17A is increasingly implicated in DR development, the underlying...
5.
Zhu M, Li N, Wang Y, Gao S, Wang J, Shen X
Cell Tissue Res
. 2022 Apr;
388(3):521-533.
PMID: 35394215
The inflammatory changes seem to play an important role in the development of diabetic retinopathy (DR). Anti-VEGF therapy has been testified to inhibit inflammation in animal models of diabetes, but...
6.
Zhang Y, Zhu M, Mo J, Xian L
Aging (Albany NY)
. 2021 Dec;
13(24):26118-26136.
PMID: 34954689
Esophageal cancer (ESCA) is a common malignancy in the digestive system with a high mortality rate and poor prognosis. Tumor microenvironment (TME) plays an important role in the tumorigenesis, progression...
7.
Bai Y, Yang S, Zhu M, Fan C
Materials (Basel)
. 2021 Nov;
14(21).
PMID: 34771822
In this study, using synchrotron radiation X-ray imaging, the microstructure, tensile properties, and fatigue properties of FGH96 nickel-based superalloy were tested, and the fatigue damage mechanism was analyzed. An analysis...
8.
Wang Y, Chen W, Zhu M, Xian L
Front Mol Biosci
. 2021 Aug;
8:692530.
PMID: 34395526
Lung adenocarcinoma (LUAD) is a malignant tumor with high heterogeneity and poor prognosis. Ferroptosis, a form of regulated cell-death-related iron, has been proven to trigger inflammation-associated immunosuppression in the tumor...
9.
Zhang Y, Wang D, Zhu T, Yu J, Wu X, Lin W, et al.
J Cell Mol Med
. 2020 Dec;
25(1):600-612.
PMID: 33320435
Hepatocellular carcinoma (HCC) is a common disease with a significant mortality, and there is no effective treatment for advanced patients. Growing evidence indicates that circRNAs are closely related to HCC...
10.
Zhang X, Cai H, Zhu M, Qian Y, Lin S, Li X
Medicine (Baltimore)
. 2020 Apr;
99(17):e19971.
PMID: 32332683
Coronary artery disease (CAD) is the second leading cause of death after stroke in China. Percutaneous coronary intervention (PCI) significantly improves the prognosis of CAD patients. This study aimed to...